ScholarIQanswers from OpenAlex
Rheumatoid Arthritis Research and Therapies
TopicLeading institutions, researchers & key papers
Rheumatoid Arthritis Research and Therapies is a topic indexed in ScholarIQ from OpenAlex.
What is known about Rheumatoid Arthritis Research and Therapies?
ScholarIQrecord summary
This cluster of papers focuses on the pathogenesis, classification, management, and treatment outcomes of rheumatoid arthritis. It covers topics such as the role of inflammation, biological and disease-modifying therapies, autoantibodies, joint inflammation, cytokines, cardiovascular risk, synoviocytes, and the genetic contribution to the disease.
How many works does Rheumatoid Arthritis Research and Therapies have?
ScholarIQindexed works
Rheumatoid Arthritis Research and Therapies has 855 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Rheumatoid Arthritis Research and Therapies?
ScholarIQopenalex
The OpenAlex for Rheumatoid Arthritis Research and Therapies is on the source record.
What are the most-cited papers on Rheumatoid Arthritis Research and Therapies?
ScholarIQmost cited works
2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
Daniel Aletaha, Tuhina Neogi, Alan J. Silman, Julia Funovits, David T. Felson, Clifton O. Bingham, Neal S. Birnbaum, Gerd R Burmester, Vivian P. Bykerk, Marc D. Cohen, Bernard Combe, Karen H. Costenbader, Maxime Dougados, Paul Emery, Gianfranco Ferraccioli, Johanna M. W. Hazes, Kathryn Hobbs, T. Huizinga, Arthur Kavanaugh, Jonathan Kay, Tore K. Kvien, Timothy Laing, Philip J. Mease, Henri A. Ménard, Larry W. Moreland, Raymond L. Naden, Theodore Pincus, Josef S Smolen, Ewa Stanisławska‐Biernat, Deborah Symmons, Paul P. Tak, Katherine S. Upchurch, Jiří Vencovský, Frederick Wolfe, Gillian Hawker
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S Smolen, Robert Landewé, Johannes Bijlsma, Gerd Burmester, Katerina Chatzidionysiou, Maxime Dougados, J. Nam, Sofía Ramiro, Marieke Voshaar, Ronald van Vollenhoven, Daniel Aletaha, Martin Aringer, Maarten Boers, Christopher D. Buckley, Frank Buttgereit, Vivian P. Bykerk, Mario Cardiel, Bernard Combe, Maurizio Cutolo, Yvonne van Eijk‐Hustings, Paul Emery, Axel Finckh, Cem Gabay, Juan J. Gómez‐Reino, Laure Gossec, J.-E. Gottenberg, Johanna M W Hazes, T. Huizinga, Meghna Jani, Д. Е. Каратеев, Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain B. McInnes, Eduardo Mysler, Peter Nash, Karel Pavelká, Gyula Poór, Christophe Richez, Piet L. C. M. van Riel, Andrea Rubbert‐Roth, Kenneth G. Saag, José António Pereira da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée van der Heijde
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
D. Aletaha, Tuhina Neogi, Alan J. Silman, Julia Funovits, David T. Felson, Clifton O. Bingham, Neal S Birnbaum, Gerd‐Rüdiger Burmester, V. P. Bykerk, Marc D. Cohen, B. Combe, Karen H. Costenbader, M. Dougados, P. Emery, Gianfranco Ferraccioli, Johanna M. W. Hazes, Kathryn Hobbs, T. Huizinga, A. Kavanaugh, Jonathan Kay, T.K. Kvien, Timothy Laing, Philip J. Mease, Henri A Ménard, Larry W. Moreland, Raymond L. Naden, Theodore Pincus, Josef S Smolen, E. Stanislawska-Biernat, Deborah Symmons, P. P. Tak, Katherine S. Upchurch, Jiří Vencovský, Fred Wolfe, Gillian Hawker
Evolving concepts of rheumatoid arthritis
Gary S. Firestein
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair, Daniel E. Fürst, Ferdinand C. Breedveld, Joachim R. Kalden, Josef S Smolen, Michael H. Weisman, Paul Emery, Marc Feldmann, Gregory R. Harriman, Ravinder N. Maini
Where is Rheumatoid Arthritis Research and Therapies research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Rheumatoid Arthritis Research and Therapies is open access?
ScholarIQopen access share
53%OPEN ACCESS